True Capital Management’s Merck MRK Stock Holding History

True Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$246K	Buy	+2,310	New	+$249K	0.17%	115

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

True Capital Management's MRK Position: Q1 2023 in Review

True Capital Management opened a new position in Merck (MRK) in Q1 2023: 2,310 shares worth $246K. The stake represents 0.17% of the portfolio and ranks #115 among its holdings.

3,179 funds tracked by Wall St. Rank hold MRK as of Q1 2023.

True Capital Management held 2,310 shares of Merck worth $246K as of Q1 2023.
Merck was a new True Capital Management position in Q1 2023.
Merck made up 0.17% of True Capital Management's portfolio in Q1 2023, its #115 holding.
3,179 funds tracked by Wall St. Rank held Merck as of Q1 2023.

Based on True Capital Management's 13F filing for Q1 2023, filed 2 May 2023.